Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Grassley’s Swing At Illegal Anabolic Steroid Use Unfairly Strikes DHEA – CRN

This article was originally published in The Tan Sheet

Executive Summary

Legislation introduced in response to a report on steroid use in Major League Baseball that would put an age restriction on sales of performance-enhancing drugs and supplements - including DHEA - is a "misdirected attempt ... based on emotional rhetoric" to curb illegal anabolic steroid use, industry leaders say

You may also be interested in...



HGH Import Alert Grows From 4 Products To 32 In 8 Months

An April 18 alert update about a Chinese firm distributing HGH-containing supplements follows the launch of the alert in September and an update in November about other firms in the country reported as shipping supplements tainted with the ingredient.

Elections’ Effects On Regulators, Leadership May Hit Supplement Industry

Regulators likely will seek to broaden their reach under existing authority if Republicans win control of the House on Nov. 2 as predicted, said John Gay, executive director and CEO of the Natural Products Association.

Elections’ Effects On Regulators, Leadership May Hit Supplement Industry

Regulators likely will seek to broaden their reach under existing authority if Republicans win control of the House on Nov. 2 as predicted, said John Gay, executive director and CEO of the Natural Products Association.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101226

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel